Heart disease in hemodialysis: physiopathology and therapeutic breakthroughs

Nephrol Ther. 2023 Nov 2;19(6):542-551. doi: 10.1684/ndt.2023.47.ABSTRACTEspecially exposed to frequent cardiovascular events and its related mortality, some cardiovascular therapies of the hemodialyzed population as well as coronary investigations remain controversial. We have collected data and discussed recent trials and guidelines dedicated to this patient subset.PMID:37915198 | DOI:10.1684/ndt.2023.47
Source: Nephrologie and Therapeutique - Category: Urology & Nephrology Authors: Source Type: research